blog

TSO and MS: Phase 1 Clincal Trial Complete

Posted Sunday, April 10, 2011 by SJohnson
Comments: 0

The Phase 1 clinical trial of TSO for treatment of Multiple Sclerosis, conducted by Dr.Fleming at the University of Wisconsin School of Medicine and Public Health, is now complete. No adverse effects in the 5 patients, and a reduction of MRI-measured brain leasions in all 5. The abstract is available here

Comments

There are currently no comments for this post

Upcoming Events

Mount Sinai School of Medicine - December 2009

Clinical Trial of TSO for Autism Recruiting

clinicaltrials.gov
A 16 week, open-label trial of TSO to assess the effect on repetitive behaviors, aggression and irritability, and global functioning in adults with autistic disorder is currently recruiting patients.

Recent Blog Posts

04/10/2011

blog

TSO and MS: Phase 1 Clincal Trial Complete

Comments

Upcoming Events

Clinical Trial of TSO for Autism Recruiting

Recent Blog Posts

TSO and MS: Phase 1 Clincal Trial Complete

Article on TSO and my son in The Scientist

Textbook chapter on my experience with TSO

Scientists uncover a mechanism of action in helminth therapy